3C
HOLX

361 Capital’s Hologic HOLX Stock Holding History

361 Capital’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$251K Buy
+4,400
New +$216K 0.12% 274

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

361 Capital's HOLX Position: Q2 2020 in Review

361 Capital opened a new position in Hologic (HOLX) in Q2 2020: 4,400 shares worth $251K. The stake represents 0.12% of the portfolio and ranks #274 among its holdings.

522 funds tracked by Wall St. Rank hold HOLX as of Q2 2020.

  • 361 Capital held 4,400 shares of Hologic worth $251K as of Q2 2020.
  • Hologic was a new 361 Capital position in Q2 2020.
  • Hologic made up 0.12% of 361 Capital's portfolio in Q2 2020, its #274 holding.
  • 522 funds tracked by Wall St. Rank held Hologic as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.